Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Immunostimulatory bacteria engineered to colonize tumors, tumor-resident immune cells, and the tumor microenvironment

Immunostimulatory bacteria engineered to colonize tumors, tumor-resident immune cells, and the tumor microenvironment

US Patent 12024709 · Granted Jul 2, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Engineered immunostimulatory bacterial strains and uses thereof2025
Engineered immunostimulatory bacterial strains and uses thereof2025
Engineered immunostimulatory bacterial strains and uses thereof2025
Engineered immunostimulatory bacterial strains and uses thereof2025
Modified urokinase-type plasminogen activator polypeptides and methods of use2025
Modified amino acids2025
Modified Fc proteins comprising site-specific non-natural amino acid residues, c2025
Engineered immunostimulatory bacterial strains and uses thereof2025
Engineered immunostimulatory bacterial strains and uses thereof2025
Engineered immunostimulatory bacterial strains and uses thereof2025
Engineered immunostimulatory bacterial strains and uses thereof2025
Engineered immunostimulatory bacterial strains and uses thereof2025